Oscoz-Susino, Natalia
Gómez-Elías, Matias D.
Bisioli, Claudio
Horton, Marcos https://orcid.org/0000-0002-7163-6482
Papayannis, Mercedes
Martino, Evelyn De
Kopcow, Laura
Attie, Martin
Lavolpe, Mariano
Carizza, Carlos
Luque, Guillermina M.
Graf, Carolina Baro
Monserrat, Valentina Torres
Navall, Estefania
Buffone, Mariano G.
Krapf, Dario
Article History
Received: 29 January 2026
Accepted: 4 May 2026
First Online: 2 June 2026
Declarations
:
: The study protocol was approved by the Ethics Committee of IBYME-CONICET (Ref: CE001/April 2019), and the clinical trial was registered at ClinicalTrials.gov (NCT05680363). All patients provided written informed consent. The study was carried out in accordance with institutional guidelines and the ethical principles of the Declaration of Helsinki (1964) and its subsequent amendments.
: Not applicable.
: MGB, DK, GML and MDGE are shareholders of Fecundis. GML is a member of the Editorial Board of Journal of Translational Medicine. GML was not involved in the review or editorial process for this paper, on which she is listed as an author. The rest of the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.